“Real-World Evidence Confirms Risk Stratification of the 31-GEP and i31-GEP in Prospectively Tested Patients With Stage I-III Cutaneous Melanoma ”. 2024. SKIN The Journal of Cutaneous Medicine 8 (2): s386. https://doi.org/10.25251/skin.8.supp.386.